Clopidogrel pathway.

Article Details

Citation

Copy to clipboard

Sangkuhl K, Klein TE, Altman RB

Clopidogrel pathway.

Pharmacogenet Genomics. 2010 Jul;20(7):463-5. doi: 10.1097/FPC.0b013e3283385420.

PubMed ID

20440227 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Clopidogrel	Cytochrome P450 1A2	Protein	Humans	No	Substrate	Details
Clopidogrel	Cytochrome P450 2B6	Protein	Humans	No	Substrate Inhibitor	Details

Drug Interactions

• Approved
• Vet approved
• Nutraceutical
• Illicit
• Withdrawn
• Investigational
• Experimental
• All Drugs

Drugs	Interaction
Integrate drug-drug interactions in your software
Clopidogrel Rifabutin	The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifabutin.
Clopidogrel Rifampicin	The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifampicin.
Clopidogrel Rifapentine	The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifapentine.
Clopidogrel Rifaximin	The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifaximin.
Clopidogrel Rifamycin	The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rifamycin.